Akt: a potential target for thyroid cancer therapy

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Thyroid cancer is a complex disease driven by genetic mutations affecting signaling pathways, tumor suppressors, and cell cycle proteins.
• The Akt/PKB signaling pathway plays a significant role in thyroid tumorigenesis and progression.
• Activation of the Akt pathway is observed in Cowden's syndrome and sporadic thyroid cancers.

Purpose of the Study:

• To investigate the role of the Akt signaling pathway in thyroid cancer.
• To explore the potential of targeting the Akt pathway for thyroid cancer therapy.

Main Methods:

• Analysis of gene mutations and signaling pathway activation in thyroid cancer.
• Investigating Akt pathway activation via PTEN inactivation in Cowden's syndrome.
• Examining Akt pathway activation in sporadic thyroid cancers through growth factor pathways.
• In vitro studies using pharmacological inhibition of PI3-kinase and dominant-negative Akt cDNA.

Main Results:

• Akt pathway activation is a key event in thyroid cancer initiation and progression.
• PTEN inactivation leads to Akt activation in Cowden's syndrome, associated with thyroid, breast, and colon cancers.
• Sporadic thyroid cancers show Akt pathway activation linked to oncogenes and receptor overexpression.
• Inhibition of PI3-kinase or Akt signaling demonstrated therapeutic effects in cancer models.

Conclusions:

• The Akt signaling pathway is a critical driver in various thyroid malignancies.
• Targeting the Akt pathway presents a promising therapeutic strategy for thyroid cancer treatment.
• Akt is an attractive target for pharmaceutical development in multiple cancer types.